Bridgewater Associates’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $8.11M | Sell |
|
|||||
|
2025
Q2 | $22.2M | Buy |
|
|||||
|
2025
Q1 | $4.87M | Sell |
|
|||||
|
2024
Q4 | $7.62M | Sell |
|
|||||
|
2024
Q3 | $21.4M | Sell |
|
|||||
|
2024
Q2 | $39.4M | Sell |
|
|||||
|
2024
Q1 | $51.4M | Sell |
|
|||||
|
2023
Q4 | $53.8M | Sell |
|
|||||
|
2023
Q3 | $56.1M | Buy |
|
|||||
|
2023
Q2 | $53.7M | Sell |
|
|||||
|
2023
Q1 | $52.9M | Buy |
|
|||||
|
2022
Q4 | $48.9M | Sell |
|
|||||
|
2022
Q3 | $50.2M | Sell |
|
|||||
|
2022
Q2 | $47.2M | Buy |
|
|||||
|
2022
Q1 | $74.3M | Buy |
|
|||||
|
2021
Q4 | $57.2M | Buy |
|
|||||
|
2021
Q3 | $51.5M | Sell |
|
|||||
|
2021
Q2 | $45M | Buy |
|
|||||
|
2021
Q1 | $13.1M | Buy |
|
|||||
|
2020
Q4 | $12M | Buy |
|
|||||
|
2020
Q3 | $7.18M | Buy |
|